← Browse by Condition
Medical Condition
oral cavity cancer
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2
NCT07209189 Phase 2
Recruiting
Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)
Enrollment
75 pts
Location
United States
Sponsor
Sidney Kimmel Comprehensive Ca...
NCT07063212 Phase 2
Recruiting
A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
Enrollment
40 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...
NCT05793151
Recruiting
Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy
Enrollment
532 pts
Location
United States
Sponsor
Medical University of South Ca...